- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.45 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 2 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 2 x VO4: VANADATE ION(Non-covalent)
VO4.2: 11 residues within 4Å:- Chain A: S.180, G.181, K.184, N.238, S.241, S.242, R.243, A.463, G.464
- Ligands: ADP.1, MG.3
9 PLIP interactions:9 interactions with chain A- Hydrogen bonds: A:G.181, A:K.184, A:N.238, A:S.241, A:S.242, A:S.242, A:S.242, A:R.243, A:G.464
VO4.19: 11 residues within 4Å:- Chain B: S.180, G.181, K.184, N.238, S.241, S.242, R.243, A.463, G.464
- Ligands: ADP.18, MG.20
10 PLIP interactions:10 interactions with chain B- Hydrogen bonds: B:E.179, B:G.181, B:K.184, B:N.238, B:S.241, B:S.242, B:R.243, B:G.464
- Water bridges: B:T.185, B:N.240
- 2 x MG: MAGNESIUM ION(Non-covalent)
MG.3: 4 residues within 4Å:- Chain A: T.185, S.242
- Ligands: ADP.1, VO4.2
4 PLIP interactions:2 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:T.185, A:S.242, H2O.1, H2O.1
MG.20: 4 residues within 4Å:- Chain B: T.185, S.242
- Ligands: ADP.18, VO4.19
4 PLIP interactions:2 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:T.185, B:S.242, H2O.15, H2O.15
- 2 x 2OW: methyl 4-(2-fluoro-3-{[(6-methylpyridin-3-yl)carbamoyl]amino}benzyl)piperazine-1-carboxylate(Non-covalent)
2OW.4: 17 residues within 4Å:- Chain A: K.146, R.147, N.160, Q.163, Y.164, T.167, D.168, H.492, H.666, P.710, N.711, R.712, I.713, R.721, Y.722, L.770, E.774
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:T.167, A:I.713, A:L.770
- Hydrogen bonds: A:D.168, A:N.711, A:R.712, A:R.712
- Salt bridges: A:E.774
- pi-Stacking: A:H.666
2OW.21: 18 residues within 4Å:- Chain B: K.146, R.147, N.160, Q.163, Y.164, T.167, D.168, H.492, H.666, P.710, N.711, R.712, I.713, R.721, Y.722, F.765, L.770, E.774
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:T.167, B:I.713, B:I.713, B:F.765, B:L.770
- Hydrogen bonds: B:Y.164, B:D.168, B:N.711, B:R.712, B:R.712
- pi-Stacking: B:H.666
- 25 x GOL: GLYCEROL(Non-functional Binders)
GOL.5: 8 residues within 4Å:- Chain A: N.361, M.362, K.363, D.376, G.377, T.378, E.379, E.380
Ligand excluded by PLIPGOL.6: 8 residues within 4Å:- Chain A: F.494, Q.498, F.510, I.511, D.512, F.513, G.514, M.515
Ligand excluded by PLIPGOL.7: 10 residues within 4Å:- Chain A: F.244, G.245, Y.266, L.267, I.462, A.463, C.477, I.478, T.481, H.651
Ligand excluded by PLIPGOL.8: 6 residues within 4Å:- Chain A: E.269, S.271, R.272, F.275, E.474, Q.475
Ligand excluded by PLIPGOL.9: 5 residues within 4Å:- Chain A: M.6, A.7, F.9, R.17, P.151
Ligand excluded by PLIPGOL.10: 4 residues within 4Å:- Chain A: F.275, L.277, F.470, P.573
Ligand excluded by PLIPGOL.11: 7 residues within 4Å:- Chain A: L.267, L.268, E.269, K.270, S.271, E.474, V.647
Ligand excluded by PLIPGOL.12: 6 residues within 4Å:- Chain A: V.236, L.277, A.279, F.468, D.469, F.470
Ligand excluded by PLIPGOL.13: 6 residues within 4Å:- Chain A: E.537, F.540, K.542, A.543, T.547, K.551
Ligand excluded by PLIPGOL.14: 3 residues within 4Å:- Chain A: W.130, L.131, P.132
Ligand excluded by PLIPGOL.15: 2 residues within 4Å:- Chain A: D.382, K.383
Ligand excluded by PLIPGOL.16: 2 residues within 4Å:- Chain A: R.739, H.760
Ligand excluded by PLIPGOL.17: 3 residues within 4Å:- Chain A: Q.498, K.502, F.510
Ligand excluded by PLIPGOL.22: 6 residues within 4Å:- Chain B: D.382, A.385, Y.386, L.390, N.391, S.392
Ligand excluded by PLIPGOL.23: 9 residues within 4Å:- Chain B: G.245, Y.266, L.267, I.462, A.463, C.477, I.478, T.481, H.651
Ligand excluded by PLIPGOL.24: 7 residues within 4Å:- Chain B: V.236, L.277, K.278, A.279, F.468, D.469, F.470
Ligand excluded by PLIPGOL.25: 7 residues within 4Å:- Chain B: F.494, Q.498, F.510, I.511, D.512, F.513, M.515
Ligand excluded by PLIPGOL.26: 5 residues within 4Å:- Chain B: R.403, Y.410, E.603, T.604, D.607
Ligand excluded by PLIPGOL.27: 4 residues within 4Å:- Chain A: G.253, A.254, P.452
- Chain B: E.536
Ligand excluded by PLIPGOL.28: 9 residues within 4Å:- Chain B: E.269, S.271, R.272, F.275, L.277, E.280, F.468, E.474, Q.475
Ligand excluded by PLIPGOL.29: 5 residues within 4Å:- Chain B: E.64, Y.103, K.106, E.107, A.110
Ligand excluded by PLIPGOL.30: 3 residues within 4Å:- Chain B: W.130, L.131, P.132
Ligand excluded by PLIPGOL.32: 6 residues within 4Å:- Chain A: V.795, M.799
- Chain D: L.176, A.178, G.179, H.195
Ligand excluded by PLIPGOL.33: 6 residues within 4Å:- Chain A: R.793
- Chain D: R.85, Q.93, K.167, E.172
- Ligands: GOL.34
Ligand excluded by PLIPGOL.34: 5 residues within 4Å:- Chain D: R.85, Q.93, V.96, L.108
- Ligands: GOL.33
Ligand excluded by PLIP- 1 x TCE: 3,3',3''-phosphanetriyltripropanoic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Planelles-Herrero, V.J. et al., Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil. Nat Commun (2017)
- Release Date
- 2017-08-16
- Peptides
- Myosin-7: AB
Myosin light chain 3: CD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
GD
H
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.45 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 2 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 2 x VO4: VANADATE ION(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 2 x 2OW: methyl 4-(2-fluoro-3-{[(6-methylpyridin-3-yl)carbamoyl]amino}benzyl)piperazine-1-carboxylate(Non-covalent)
- 25 x GOL: GLYCEROL(Non-functional Binders)
- 1 x TCE: 3,3',3''-phosphanetriyltripropanoic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Planelles-Herrero, V.J. et al., Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil. Nat Commun (2017)
- Release Date
- 2017-08-16
- Peptides
- Myosin-7: AB
Myosin light chain 3: CD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
GD
H